Comparison of Weaning Strategies in Patients Receiving Venovenous Extracorporeal Membrane Oxygenation: An Exploratory Retrospective Study

Abstract

Venovenous extracorporeal membrane oxygenation (VV ECMO) facilitates the reduction of mechanical ventilation (MV) support in acute respiratory failure. Contrary to increasing evidence regarding its initiation, the optimal timing of VV ECMO weaning in interaction with MV weaning is undetermined. In this retrospective study, 47 patients who received VV ECMO between 2013 and 2021 and survived ≥1 day after ECMO cessation were divided according to their MV status before ECMO removal: 28 patients were classified into an “ECMO weaning during assisted MV/spontaneous breathing” group and 19 into an “ECMO weaning during controlled MV” group. Extracorporeal membrane oxygenation duration was longer in the “assisted MV/spontaneous breathing” group (17 [Interquartile range (IQR) = 11–35] vs. 6 [5–11] days, p < 0.001). These patients had a longer intensive care unit (ICU) stay after ECMO start (48 [29–66] vs. 31 [15–40] days, p = 0.01). No significant differences were found for MV duration after ECMO start (30 [19–45] vs. 19 [12–30] days, p = 0.06) and further ICU survival (86% vs. 89%, p ≥ 0.9). There was a trend toward more patients with mechanical ECMO complications in the “assisted MV/spontaneous breathing” group (57% vs. 32%, p = 0.08). Thus, our results suggest a possible benefit of early ECMO weaning during controlled MV.